Citation: Alw. Po et Mj. Kendall, Causality assessment of adverse effects - When is re-challenge ethically acceptable?, DRUG SAFETY, 24(11), 2001, pp. 793-799
Authors:
Zhang, WY
Po, ALW
Dua, HS
Azuara-Blanco, A
Citation: Wy. Zhang et al., Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension, BR J OPHTH, 85(8), 2001, pp. 983-990
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol - In the treatment of mild to moderate plaque psoriasis, PHARMACOECO, 18(5), 2000, pp. 469-476
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Systematic review of comparative efficacy and tolerability of calcipotriolin treating chronic plaque psoriasis, BR MED J, 320(7240), 2000, pp. 963-967
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Combination regimens of topical calcipotriene in chronic plaque psoriasis - Systematic review of efficacy and tolerability, ARCH DERMAT, 136(12), 2000, pp. 1536-1543
Citation: Yl. Wu et al., Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations, APMIS, 107(6), 1999, pp. 585-592
Citation: Yl. Wu et al., Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa, J ANTIMICRO, 44(3), 1999, pp. 389-392
Citation: Alw. Po et Mj. Kendall, Causality assessment of adverse drug effects: when is rechallenge ethically acceptable?, LANCET, 354(9179), 1999, pp. 683-683
Citation: C. Liu et al., "Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis - Reply, J NE NE PSY, 66(4), 1999, pp. 553-554
Authors:
Ashcroft, DM
Po, ALW
Williams, HC
Griffiths, CEM
Citation: Dm. Ashcroft et al., Clinical measures of disease severity and outcome in psoriasis: a criticalappraisal of their quality, BR J DERM, 141(2), 1999, pp. 185-191
Citation: Alw. Po, The British National Health Service (NHS) celebrates its 50th anniversary:equity in a competitive world, J CLIN PH T, 23(4), 1998, pp. 241-242
Authors:
Williams, H
Adetugbo, K
Po, ALW
Naldi, L
Diepgen, T
Murrell, D
Citation: H. Williams et al., The Cochrane Skin Group - Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology, ARCH DERMAT, 134(12), 1998, pp. 1620-1626